Figure 5. Reduction in breast cancer mortality (R(d)) vs age at first screen for regimens employing a final screen at age 64 years (
), 66 years (
), 68 years (
) and 70 years (
). The interval between successive screens is 3 years in each case.
Figure 5. Reduction in breast cancer mortality (R(d)) vs age at first screen for regimens employing a final screen at age 64 years (), 66 years (), 68 years () and 70 years (). The interval between successive screens is 3 years in each case.